APIDRA
INSULINE GLULISINE
Public price
98,40 MAD
Active substance
INSULINE GLULISINE
Laboratory
SANOFI AVENTIS MAROC
Reimbursable
What is this medicine?
APIDRA: This substance is used in diabetes management. It acts on blood glucose through a mechanism that depends on the active ingredient.
Verified summary
INSULINE GLULISINE, SOLUTION INJECTABLE, 100 UI / ML, BOITE DE 1 CARTOUCHE DE 3 ML
Common uses
Common uses: type 2 diabetes or insulin needs, metabolic follow-up, and blood-glucose control according to patient profile. General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Diabetology - antidiabetic
Laboratory
SANOFI AVENTIS MAROC
Availability note
Reimbursable
Hospital price
61,50 MAD
Strength
100 UI / ML
Form
SOLUTION INJECTABLE
Presentation
BOITE DE 1 CARTOUCHE DE 3 ML
Commercial status
Retiré du Marché
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 98,40 MAD
Available presentations and strengths
Medicines with the same active substance
APIDRA 100 U / ML
3 ml · Boîte de 1 cartouche de 3 ml
98,40 MAD
APIDRA SOLOSTAR 100 U / ML
100 U / ML, · Boîte d'un stylo pré-rempli de 3 ml
98,40 MAD
APIDRA SOLOSTAR 100 U / ML
Solution injectable [Ins]
98,40 MAD
APIDRA 100 U / ML
3 ml · Boîte de 5 cartouches de 3 ml
366,00 MAD
APIDRA SOLOSTAR 100 U / ML
3 ml · Boîte de 5 stylos pré-remplis de 3 ml
439,00 MAD